(Q50802741)

19 March 2018

title

Structural changes in the midbrain with aging and Parkinson's disease: an MRI study. (English)

1 reference

19 March 2018

1 reference

Makoto Sohmiya

1

1 reference

19 March 2018

Makoto Tanaka

series ordinal

2

1 reference

19 March 2018

Yoshiaki Aihara

series ordinal

3

1 reference

19 March 2018

Koichi Okamoto

series ordinal

4

1 reference

19 March 2018

publication date

1 April 2004

1 reference

19 March 2018

published in

Neurobiology of Aging

1 reference

19 March 2018

volume

25

1 reference

19 March 2018

issue

4

1 reference

19 March 2018

page(s)

449-453

1 reference

19 March 2018

T2 relaxation time in patients with Parkinson's disease.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900125-8

7 January 2021

Criteria for diagnosing Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900125-8

7 January 2021

Sex differences in brain aging: a quantitative magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900125-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900125-8

1 reference

7 January 2021

Magnetic resonance imaging of the midbrain in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900125-8

7 January 2021

Ageing and Parkinson's disease: substantia nigra regional selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900125-8

7 January 2021

Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900125-8

7 January 2021

Parkinsonism: onset, progression, and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900125-8

7 January 2021

A comparison of (18)F-dopa PET and inversion recovery MRI in the diagnosis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900125-8

7 January 2021

Magnetic resonance imaging in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900125-8

7 January 2021

Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 Tesla.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900125-8

7 January 2021

Reduction of the substantia nigra width and motor decline in aging and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900125-8

7 January 2021

Imaging of brain iron by magnetic resonance: T2 relaxation at different field strengths

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900125-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900125-8

7 January 2021

Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900125-8

7 January 2021

Magnetic resonance imaging of brain iron in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900125-8

7 January 2021

The quantitative relation between T1-weighted and T2-weighted MRI of normal gray matter and iron concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900125-8

7 January 2021

10.1016/S0197-4580(03)00125-8

Identifiers

DOI

1 reference

19 March 2018

1 reference

19 March 2018